HOME >> BIOLOGY >> NEWS
UC given $1 million to develop skin cancer prevention treatment

A research team led by University of Cincinnati (UC) scientists has received $1 million from the National Cancer Institute to develop a new topical treatment that would not only increase skin pigmentation to block harmful ultraviolet (UV) rays, but also repair damage that can lead to skin cancer.

The researchers will work with a chemically modified hormone called alpha-melanocyte stimulating hormone (alpha-MSH). Known to increase skin pigmentation--the "tan" that reduces dangerous UV ray penetration--alpha-MSH has also been found to repair precancerous damage that UV rays do to skin cell DNA, the genetic material within cells.

"We hope to develop a new topical cream that will prevent skin cancer by both increasing skin pigmentation and at the same time repairing DNA damage caused by UV radiation," says study leader Zalfa Abdel-Malek, PhD, of UC's dermatology department.

"We have already shown that alpha-MSH repairs DNA damage caused by excessive sun exposure, thus reversing the cancer-causing effects of UV radiation," says Abdel-Malek, who has studied this phenomenon in isolated human melanocytes, the cells that produce the tanning pigment melanin.

Abdel-Malek will work with Ana Luisa Kadekaro, PhD, a UC dermatology instructor, to determine the ability of alpha-MSH, and synthesized versions of it, to reduce DNA damage in melanocytes that have been exposed to UV radiation in the lab.

To make it easier for the hormone to penetrate the fatty lipid layer of the skin, team members James Knittel, PhD, of UC's College of Pharmacy, and Carrie Haskell-Luevano, PhD, of the University of Florida, have already reduced alpha-MSH from its original peptide chain of 13 amino acids to a chain of only four amino acids. They hope to make the chain even smaller, and consequently more effective at penetrating the skin to target the melanocytes.

Dorothy Supp, PhD, of UC's department of surgery, will study the synthesized pe
'"/>

Contact: Sheryl Hilton
sheryl.hilton@uc.edu
513-558-4561
University of Cincinnati
3-Nov-2006


Page: 1 2

Related biology news :

1. St. Jude shows gene test not needed if cancer drug given in low doses
2. Anthropologist given one of nations top scientific honors
3. Novel approach to cancer drug given major boost
4. Drug can reduce severe bleeding in mothers who have just given birth
5. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
6. Once given no respect, cells tiny RNAS take drivers seat
7. Six research units given the go-ahead
8. US Department of Defense awards $1.6 million for implantable biochip research
9. Nottingham biosciences million pound injection
10. $9 million EPSCoR grant to foster integrated research
11. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/22/2019)... ... 21, 2019 , ... The inventors of a new and ... major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert ... from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for ...
(Date:11/19/2019)... ... November 19, 2019 , ... Project Lifeline – ... Stores (NACDS) Foundation to address substance use disorder (SUD) – will take ... who have led to the program’s effectiveness in preventing and treating opioid abuse in ...
(Date:11/19/2019)... ... , ... The inaugural Cell & Gene Therapy Day takes place February 27, ... will be chaired by Dr Aiman Shalabi, VP R&D, Cell and Gene Therapies for ... witnessing significant innovation in cell and gene therapies, and we are at a turning ...
Breaking Biology News(10 mins):
(Date:11/6/2019)... ... November 06, 2019 , ... LeadingBiotech ,?an exclusive ... announces its East/West CEO conference to be held January 11-12, 2020 ... Kicking off the week of the J.P. Morgan Healthcare Conference and other biotech ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... it has received CE Mark for its Fusion Bx 2.0 prostate fusion biopsy ... user-friendly interface, the Fusion Bx 2.0 will give urologists across Europe the ability ...
(Date:11/2/2019)... TORONTO (PRWEB) , ... October 31, 2019 , ... ... are not always used to communicating with each other: study managers, principal investigators, ... cause misunderstandings if a party is not informed of the latest data, potentially ...
(Date:11/2/2019)... ... October 31, 2019 , ... ... pharma artificial intelligence pioneer tellic. drug360 brings tellic’s expertise in biomedical language ... allows researchers to quickly uncover relationships between genes, diseases, variants, phenotypes, and other ...
Breaking Biology Technology:
Cached News: